Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
123.50    1.50 (1.24%)
Bid:
121.00
Ask:
123.50
Spread: 2.50 (2.066%)
Market Cap: £196.76m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Pre-close Trading Update

31 Mar 2016 07:00

RNS Number : 6047T
Redcentric PLC
31 March 2016
 

31 March 2016

Redcentric plc

("Redcentric" or the "Company")

 

Pre-close Trading Update

 

Redcentric plc (AIM:RCN), a leading UK IT managed services provider, is today issuing a pre-close trading update for the second half of the financial year to 31 March 2016.

 

The positive momentum reported at the interim results has continued through the second half of the year. Contracted revenues continue to grow, driven both through new client wins and with existing clients taking more services and products.

 

EBITDA margins have improved as we continue to improve the revenue mix to higher margin services. Overall, revenue and EBITDA are both expected to be in line with expectations.

 

City Lifeline Ltd, which was acquired for £4.8m on 29 January 2016, is performing in line with plan, and its integration into the wider Redcentric business is progressing well.

 

During the second half, the business has increased its success-based capital expenditure given the high levels of new customer activity. Following this expenditure and an increase in year-end debtors, principally reflecting the timing of some collections, the Company's balance sheet remains strong, with a net debt to adjusted EBITDA ratio of below 1.0x.

 

There is good sales momentum, with a strong pipeline of future opportunities. Overall, the Board are confident in the outlook of the business.

 

Redcentric is expecting to report results for the year to 31 March 2016 on 16 June 2016.

 

Fraser Fisher, Chief Executive Officer of Redcentric, commented;

"We're pleased with our performance in the second half of the year. The strength of our business model, with its high proportion of recurring revenue, provides stability from which we can plan our growth. We remain confident in the strength of the business to continue to successfully execute its growth strategy".

 

 

Enquiries:

 

Redcentric plc

+44 (0)845 034 111

Fraser Fisher, Chief Executive Officer

Tim Coleman, Chief Financial Officer

Numis Securities Limited - Nomad & Joint Broker

+44 (0)20 7260 1000

Simon Willis / Oliver Hardy / Ben Stoop

finnCap Ltd - Joint Broker

+44 (0)20 7220 0500

Stuart Andrews / Rhys Williams

MXC Capital Markets LLP - Financial Adviser

+44 (0)20 7965 8149

Marc Young / Charlotte Stranner

Tulchan

+44 (0)20 7353 4200

James Macey White / Matt Low

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTWGUAAWUPQGAU
Date   Source Headline
31st May 202411:46 amRNSForm 8.5 (EPT/NON-RI)
31st May 20249:23 amPRNForm 8.3 - Redcentric Plc
30th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
30th May 202410:34 amRNSForm 8.5 (EPT/NON-RI)
30th May 20249:49 amPRNForm 8.3 - Redcentric Plc
29th May 20243:13 pmRNSForm 8.3 - Redcentric PLC
29th May 202411:43 amRNSForm 8.5 (EPT/NON-RI)
29th May 20249:30 amPRNForm 8.3 - Redcentric Plc
29th May 20247:00 amRNSForm 8.3 - Redcentric plc
28th May 20245:17 pmRNSForm 8.3 - Redcentric plc
28th May 20243:57 pmRNSForm 8.3 - Redcentric plc
28th May 20242:47 pmRNSForm 8.3 - Redcentric PLC
28th May 20242:28 pmRNSSI Redstone LLP - Form 8.3 - Redcentric plc
28th May 20241:35 pmEQSForm 8.3 - Apex Fundrock Limited : Re Redcentric plc
28th May 20241:16 pmRNSForm 8.5 (EPT/NON-RI) - Amendment
28th May 202411:49 amRNSForm 8.3 - Redcentric plc
28th May 202411:06 amRNSForm 8.3 - Redcentric PLC
28th May 202410:24 amRNSForm 8.5 (EPT/NON-RI)
28th May 20249:56 amPRNCorrection: Statement regarding Redcentric plc ("Redcentric")
28th May 20249:13 amPRNStatement regarding Redcentric plc ("Redcentric")
24th May 20244:19 pmRNSResponse to press speculation
16th May 20247:00 amRNSTrading Update
14th May 20241:00 pmRNSExercise of Options
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.